According to the ICMR, 19,01,48,024 samples have been tested up to January 21 with 8,00,242 samples being tested on Thursday

Fact sheets for recipients of Moderna and Pfizer-BioNTech vaccines in US and UK clarify that the vaccines are yet to be fully approved; recipients have been asked to get help if they experience severe side effects or allergic reactions

Comprehensive contact tracing has been initiated for co-travellers, family contacts and others.  Genome sequencing on other specimens is going on, says the government

Coronavirus vaccine in India: Adar Poonawalla, CEO of Serum Institute of India that is manufacturing Covishield had said that the company is ready to roll out its vaccine in the coming weeks

Union Health Minister Dr Harsh Vardhan slammed senior Congress party leaders Shashi Tharoor and Jairam Ramesh, and Samajwadi Party leader Akhilesh Yadav for politicising the 'critical issue'

The ICMR head emphasised that the scientists at ICMR have been successfully able to culture the UK strain and the efficacy of Covaxin against it will be further tested in days to come

Calling it a great day for the country, AIIMS Director Dr Randeep Guleria said that initially Serum-AstraZeneca's Covishield will be administered to the people

COVID-19 vaccine in India: It would make every Indian proud that the two vaccines that have been given emergency use approval are made in India! This shows the eagerness of our scientific community to fulfil the dream of an Aatmanirbhar Bharat, said PM Modi

COVID-19 vaccines in India: Oxford-AstraZeneca's coronavirus vaccine Covishield and Bharat Biotech's COVID vaccine Covaxin will be India's first vaccines

The SEC has recommended Covaxin for emergency use authorisation; the recommendation, along with rollout modalities, will now be taken up by the DCGI for a final decision on the matter

Coronavirus vaccine in India: Talking about the vaccine, the minister urged people not to pay heed to any rumours. He said India became free of polio disease because of the vaccine

Suffering poor financial health, Central government has not given a concrete answer on who will bear the cost of vaccinating Indians - Centre, states, or the people themselves

Earlier only four states - Andhra Pradesh, Gujarat, Punjab and Assam, had carried out a two-day dry run to review the readiness of the mechanism laid out for the COVID-19 immunisation drive

Twenty-year-old pilot Samy Kramer flew his Diamond DA20 Katana light aircraft for 200km in a route laid out in the likeness of a syringe to celebrate the beginning of vaccination drive in Europe

According to Director of Public Health G Srinivasa Rao, 1,216 people have arrived in Telangana from the UK since December 9 and a total of 937 have been identified and tested for Covid-19

India Stock Market Highlights Today: Global equities were bearish today as coronavirus infections increased in parts of North Asia, such as Japan and South Korea, and weighed on investor sentiment. European countries have banned flights from the UK as the British government began emergency lockdown on Sunday, over fear of new virus strain.

As many as 341 new fatalities were reported in the past 24 hours, pushing the overall death toll to 1,45,477.  India's COVID-19 case fatality rate is 1.45 per cent, which is one of the lowest in the world

Despite the rise in cases, India's Covid-19 recoveries have witnessed a steep exponential rise -- from 50,000 in May to over 95 lakh in December. Recoveries are more than 30 times active cases, says  HealthMin

India Stock Market Highlights Today: In today's session, Sensex hit an all-time high of 47,026 and Nifty logged a lifetime high of 13,772.

India Stock Market Highlights Today: Global equities were buoyed today as COVID-19 vaccine developments and prospects of more stimulus boosted investor sentiment